A randomized controlled study for the long-term oncologic outcomes of robot-assisted radical anterograde modular pancreaticosplenectomy (RAMPS)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023661

Enrollment

Unknown

Registered

2019-06-05

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Group 1:Robotic RAMPS

Group 2:Conventional robotic surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Preoperative pathologic al examination or clinical judgment of resection or possible resection; 2. It meets the indications of resection of pancreatic somatococcygeal carcinoma by robot; 3. Postoperative pathological diagnosis of pancreatic ductal adenocarcinoma; 4. Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Preoperative imaging examination or intraoperative exploration revealed distant metastasis and abandonment of surgery; 2. Preoperative chemotherapy or radiotherapy; 3. Patients with major complications who cannot tolerate surgery; 4. Complicated with or secondary other malignant tumors.

Design outcomes

Primary

Measure	Time frame
Overall Survival;Disease Free Survival;	—

Secondary

Measure	Time frame
Postoperative complications;Cost;R0 Resection Rate;Perioperative indicators;	—

Countries

China

Contacts

Public ContactKang Yuhao

Chinese PLA General Hospital

29982324@qq.com+86 15810236338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026